血液指标及CT影像组学特征在建立进展为肺实变的难治性肺炎支原体肺炎预测模型中的价值探讨

    Exploration of the value of blood indices and CT radiomic features in developing a prediction model for refractory mycoplasma pneumoniae pneumonia progressing to pulmonary consolidation

    • 摘要:
      目的: 探究联合血液指标、CT影像组学特征构建的预测模型在进展为肺实变的难治性肺炎支原体肺炎诊断中的价值。
      方法: 本研究为单中心回顾性队列研究,收集1 ~ 18岁的蚌埠医科大学第一附属医院儿科确诊为肺炎支原体肺炎的120例住院患儿的临床及影像资料,其中难治性肺炎支原体肺炎60例,普通性肺炎支原体肺炎60例,所有病人经CT影像检查显示为肺实变。以7∶3为比例,将120例肺炎支原体肺炎患儿随机分为训练集和测试集。在CT图像上采用最大层面全病灶区域法勾画三维感兴趣区,按提取、筛选的顺序得到最优的组学特征,并同时提取最优的临床特征。分别建立三种进展为肺实变的难治性肺炎支原体肺炎预测模型(临床预测模型、影像组学预测模型及联合临床及影像的综合预测模型)。以ROC曲线作为评估三种模型预测效能的指标。
      结果: 难治性肺炎支原体肺炎组血小板计数、C反应蛋白、乳酸脱氢酶、D-二聚体水平明显高于普通性肺炎支原体肺炎组,差异有统计学意义(P < 0.01)。联合预测模型的预测效能最佳,其训练集曲线下面积为0.968(0.934 ~ 1.000),验证集曲线下面积为0.858(0.736 ~ 0.980),显著高于影像组学模型0.931(0.885 ~ 0.987)、0.713(0.539 ~ 0.886)和临床模型0.951(0.911 ~ 0.990)、0.923(0.840 ~ 1.000)。
      结论: 综合临床特征(C反应蛋白、D-二聚体、乳酸脱氢酶、血小板计数)及影像组学特征的联合预测模型在预测进展为肺实变的难治性肺炎支原体肺炎方面具有更高的临床意义,可以为临床制定个体化治疗方式提供一定指导。

       

      Abstract:
      Objective To investigate the value of a prediction model combining blood indices and CT radiomic features in diagnosing refractory Mycoplasma pneumoniae pneumonia (RMPP) progressing to pulmonary consolidation.
      Methods This study was a single-center retrospective cohort study that collected clinical and imaging data from 120 hospitalized pediatric patients aged 1–18 years diagnosed with Mycoplasma pneumoniae pneumonia at The First Affiliated Hospital of Bengbu Medical University, including 60 patients with RMPP and 60 with general Mycoplasma pneumoniae pneumonia (GMPP), all with pulmonary consolidation confirmed by CT imaging. The patients were randomly divided into a training set and a test set in a 7∶3 ratio. A three-dimensional region of interest (ROI) was delineated using the Maximum cross-sectional area of the entire lesion on CT images. Optimal radiomic features were obtained through extraction and screening, and optimal clinical features were selected concurrently. Three prediction models for RMPP progressing to pulmonary consolidation were established: a clinical prediction model, a radiomic prediction model, and a comprehensive prediction model combining clinical and radiomic features. The ROC curve was used to evaluate the predictive performance of the three models.
      Results The platelet (PLT) count, C-reactive protein (CRP) level, lactate dehydrogenase (LDH) level, and D-dimer level were significantly higher in the refractory group than in the general group 348.5 (279.5, 431) vs 270 (225.5, 369.5)、28.44 (11.98, 63.57) vs 10.63 (5, 27.67)、10.63 (5, 27.67) vs 291.5 (255.3, 334.5)、0.89 (0.54, 2.63) vs 0.28 (0.21, 0.43), with statistically significant differences (P < 0.05). The combined prediction model exhibited the best predictive performance, with an area under the curve (AUC) of 0.968 (0.934–1.000) for the training set and 0.858 (0.736–0.980) for the validation set, significantly higher than the radiomic model 0.931 (0.885–0.987)、0.713 (0.539–0.886) and the clinical model 0.951 (0.911–0.990)、0.923 (0.840–1.000).
      Conclusion The combined prediction model integrating clinical features (CRP, D-dimer, LDH, PLT) and radiomic features has higher clinical significance in predicting RMPP progressing to pulmonary consolidation and can provide guidance for developing individualized treatment plans in clinical practice.

       

    /

    返回文章
    返回